nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP2B6—malignant glioma	0.684	1	CbGaD
Midazolam—Skin necrosis—Carmustine—malignant glioma	0.00375	0.0612	CcSEcCtD
Midazolam—GABRR3—retina—malignant glioma	0.00286	0.0274	CbGeAlD
Midazolam—GABRQ—telencephalon—malignant glioma	0.00263	0.0252	CbGeAlD
Midazolam—GABRR2—retina—malignant glioma	0.00248	0.0237	CbGeAlD
Midazolam—GABRR1—retina—malignant glioma	0.00239	0.0228	CbGeAlD
Midazolam—GABRA6—brainstem—malignant glioma	0.00206	0.0197	CbGeAlD
Midazolam—GABRD—telencephalon—malignant glioma	0.00191	0.0183	CbGeAlD
Midazolam—Digestion impaired—Temozolomide—malignant glioma	0.0019	0.0309	CcSEcCtD
Midazolam—Thrombosis—Carmustine—malignant glioma	0.00185	0.0302	CcSEcCtD
Midazolam—GABRG1—telencephalon—malignant glioma	0.00184	0.0176	CbGeAlD
Midazolam—GABRA6—telencephalon—malignant glioma	0.00183	0.0175	CbGeAlD
Midazolam—GABRB1—telencephalon—malignant glioma	0.00178	0.017	CbGeAlD
Midazolam—GABRA5—telencephalon—malignant glioma	0.00177	0.0169	CbGeAlD
Midazolam—GABRA4—telencephalon—malignant glioma	0.00161	0.0154	CbGeAlD
Midazolam—Injection site pain—Carmustine—malignant glioma	0.00161	0.0262	CcSEcCtD
Midazolam—CYP4B1—cerebellum—malignant glioma	0.00157	0.0151	CbGeAlD
Midazolam—GABRB2—brainstem—malignant glioma	0.00151	0.0145	CbGeAlD
Midazolam—GABRD—medulla oblongata—malignant glioma	0.0015	0.0143	CbGeAlD
Midazolam—GABRQ—central nervous system—malignant glioma	0.0015	0.0143	CbGeAlD
Midazolam—GABRG1—medulla oblongata—malignant glioma	0.00144	0.0138	CbGeAlD
Midazolam—GABRB1—medulla oblongata—malignant glioma	0.0014	0.0134	CbGeAlD
Midazolam—GABRA2—brainstem—malignant glioma	0.00138	0.0132	CbGeAlD
Midazolam—GABRD—midbrain—malignant glioma	0.00137	0.0131	CbGeAlD
Midazolam—GABRG2—telencephalon—malignant glioma	0.00134	0.0129	CbGeAlD
Midazolam—GABRB2—telencephalon—malignant glioma	0.00134	0.0129	CbGeAlD
Midazolam—GABRA1—brainstem—malignant glioma	0.00134	0.0128	CbGeAlD
Midazolam—GABRG1—midbrain—malignant glioma	0.00132	0.0126	CbGeAlD
Midazolam—GABRG3—central nervous system—malignant glioma	0.00131	0.0125	CbGeAlD
Midazolam—Respiratory failure—Temozolomide—malignant glioma	0.00129	0.0211	CcSEcCtD
Midazolam—GABRG1—spinal cord—malignant glioma	0.00129	0.0123	CbGeAlD
Midazolam—GABRB1—midbrain—malignant glioma	0.00128	0.0122	CbGeAlD
Midazolam—CYP4B1—brain—malignant glioma	0.00128	0.0122	CbGeAlD
Midazolam—GABRR2—cerebellum—malignant glioma	0.00127	0.0121	CbGeAlD
Midazolam—Depressed level of consciousness—Carmustine—malignant glioma	0.00127	0.0207	CcSEcCtD
Midazolam—Skin exfoliation—Carmustine—malignant glioma	0.00125	0.0204	CcSEcCtD
Midazolam—GABRR1—central nervous system—malignant glioma	0.00125	0.0119	CbGeAlD
Midazolam—GABRB1—spinal cord—malignant glioma	0.00125	0.0119	CbGeAlD
Midazolam—GABRA2—telencephalon—malignant glioma	0.00123	0.0118	CbGeAlD
Midazolam—Depressed level of consciousness—Temozolomide—malignant glioma	0.00122	0.02	CcSEcCtD
Midazolam—Skin exfoliation—Temozolomide—malignant glioma	0.00121	0.0197	CcSEcCtD
Midazolam—GABRQ—brain—malignant glioma	0.00119	0.0114	CbGeAlD
Midazolam—GABRA1—telencephalon—malignant glioma	0.00119	0.0114	CbGeAlD
Midazolam—SLC22A1—telencephalon—malignant glioma	0.00116	0.0111	CbGeAlD
Midazolam—Phlebitis—Carmustine—malignant glioma	0.0011	0.018	CcSEcCtD
Midazolam—Thrombophlebitis—Carmustine—malignant glioma	0.0011	0.0179	CcSEcCtD
Midazolam—GABRD—central nervous system—malignant glioma	0.00108	0.0104	CbGeAlD
Midazolam—Swelling—Carmustine—malignant glioma	0.00108	0.0176	CcSEcCtD
Midazolam—Thrombophlebitis—Temozolomide—malignant glioma	0.00106	0.0173	CcSEcCtD
Midazolam—GABRD—cerebellum—malignant glioma	0.00106	0.0101	CbGeAlD
Midazolam—GABRB2—medulla oblongata—malignant glioma	0.00106	0.0101	CbGeAlD
Midazolam—GABRG2—medulla oblongata—malignant glioma	0.00106	0.0101	CbGeAlD
Midazolam—GABRG1—central nervous system—malignant glioma	0.00104	0.00999	CbGeAlD
Midazolam—GABRG3—brain—malignant glioma	0.00104	0.00995	CbGeAlD
Midazolam—GABRA6—central nervous system—malignant glioma	0.00104	0.00993	CbGeAlD
Midazolam—Injury—Carmustine—malignant glioma	0.00104	0.0169	CcSEcCtD
Midazolam—GABRB3—telencephalon—malignant glioma	0.00103	0.00988	CbGeAlD
Midazolam—GABRG1—cerebellum—malignant glioma	0.00102	0.00976	CbGeAlD
Midazolam—GABRA6—cerebellum—malignant glioma	0.00101	0.00971	CbGeAlD
Midazolam—GABRB1—central nervous system—malignant glioma	0.00101	0.00968	CbGeAlD
Midazolam—GABRA5—central nervous system—malignant glioma	0.00101	0.00963	CbGeAlD
Midazolam—GABRR1—brain—malignant glioma	0.000991	0.00948	CbGeAlD
Midazolam—GABRB1—cerebellum—malignant glioma	0.000989	0.00947	CbGeAlD
Midazolam—GABRG2—midbrain—malignant glioma	0.000965	0.00924	CbGeAlD
Midazolam—GABRB2—midbrain—malignant glioma	0.000965	0.00924	CbGeAlD
Midazolam—Diplopia—Carmustine—malignant glioma	0.000952	0.0155	CcSEcCtD
Midazolam—GABRB2—spinal cord—malignant glioma	0.000942	0.00901	CbGeAlD
Midazolam—GABRG2—spinal cord—malignant glioma	0.000942	0.00901	CbGeAlD
Midazolam—Mazindol—SLC6A3—malignant glioma	0.000937	0.165	CrCbGaD
Midazolam—GABRA3—central nervous system—malignant glioma	0.000937	0.00897	CbGeAlD
Midazolam—GABRA1—medulla oblongata—malignant glioma	0.000933	0.00892	CbGeAlD
Midazolam—Diplopia—Temozolomide—malignant glioma	0.00092	0.015	CcSEcCtD
Midazolam—GABRA4—central nervous system—malignant glioma	0.000913	0.00874	CbGeAlD
Midazolam—Affect lability—Temozolomide—malignant glioma	0.000905	0.0148	CcSEcCtD
Midazolam—Ataxia—Carmustine—malignant glioma	0.000895	0.0146	CcSEcCtD
Midazolam—GABRA4—cerebellum—malignant glioma	0.000893	0.00854	CbGeAlD
Midazolam—Mood swings—Temozolomide—malignant glioma	0.000871	0.0142	CcSEcCtD
Midazolam—Ataxia—Temozolomide—malignant glioma	0.000865	0.0141	CcSEcCtD
Midazolam—GABRD—brain—malignant glioma	0.000861	0.00824	CbGeAlD
Midazolam—GABRA1—midbrain—malignant glioma	0.000852	0.00816	CbGeAlD
Midazolam—Muscular weakness—Carmustine—malignant glioma	0.000839	0.0137	CcSEcCtD
Midazolam—GABRA1—spinal cord—malignant glioma	0.000832	0.00796	CbGeAlD
Midazolam—GABRG1—brain—malignant glioma	0.000829	0.00793	CbGeAlD
Midazolam—Clotiazepam—CYP2C18—malignant glioma	0.000824	0.145	CrCbGaD
Midazolam—GABRA6—brain—malignant glioma	0.000824	0.00788	CbGeAlD
Midazolam—Muscular weakness—Temozolomide—malignant glioma	0.000811	0.0132	CcSEcCtD
Midazolam—GABRB3—medulla oblongata—malignant glioma	0.000811	0.00776	CbGeAlD
Midazolam—GABRB1—brain—malignant glioma	0.000804	0.00769	CbGeAlD
Midazolam—GABRA5—brain—malignant glioma	0.000799	0.00765	CbGeAlD
Midazolam—Clobazam—CYP2C18—malignant glioma	0.000778	0.137	CrCbGaD
Midazolam—ABCB1—blood vessel—malignant glioma	0.000771	0.00738	CbGeAlD
Midazolam—GABRG2—central nervous system—malignant glioma	0.000764	0.00731	CbGeAlD
Midazolam—GABRB2—central nervous system—malignant glioma	0.000764	0.00731	CbGeAlD
Midazolam—GABRG2—cerebellum—malignant glioma	0.000747	0.00715	CbGeAlD
Midazolam—GABRB2—cerebellum—malignant glioma	0.000747	0.00715	CbGeAlD
Midazolam—GABRA3—brain—malignant glioma	0.000744	0.00712	CbGeAlD
Midazolam—GABRB3—midbrain—malignant glioma	0.000741	0.00709	CbGeAlD
Midazolam—Depression—Carmustine—malignant glioma	0.000731	0.0119	CcSEcCtD
Midazolam—GABRA4—brain—malignant glioma	0.000725	0.00694	CbGeAlD
Midazolam—GABRB3—spinal cord—malignant glioma	0.000723	0.00692	CbGeAlD
Midazolam—Neuropathy peripheral—Carmustine—malignant glioma	0.000719	0.0117	CcSEcCtD
Midazolam—Depression—Temozolomide—malignant glioma	0.000707	0.0115	CcSEcCtD
Midazolam—GABRA2—central nervous system—malignant glioma	0.000698	0.00668	CbGeAlD
Midazolam—Neuropathy peripheral—Temozolomide—malignant glioma	0.000695	0.0113	CcSEcCtD
Midazolam—GABRE—central nervous system—malignant glioma	0.000692	0.00662	CbGeAlD
Midazolam—GABRA2—cerebellum—malignant glioma	0.000682	0.00653	CbGeAlD
Midazolam—GABRA1—central nervous system—malignant glioma	0.000675	0.00645	CbGeAlD
Midazolam—GABRA1—cerebellum—malignant glioma	0.000659	0.00631	CbGeAlD
Midazolam—SLC22A1—central nervous system—malignant glioma	0.000659	0.00631	CbGeAlD
Midazolam—CYP2E1—telencephalon—malignant glioma	0.000657	0.00628	CbGeAlD
Midazolam—Hallucination—Carmustine—malignant glioma	0.000655	0.0107	CcSEcCtD
Midazolam—Connective tissue disorder—Carmustine—malignant glioma	0.000647	0.0106	CcSEcCtD
Midazolam—Visual impairment—Carmustine—malignant glioma	0.000634	0.0104	CcSEcCtD
Midazolam—Hallucination—Temozolomide—malignant glioma	0.000633	0.0103	CcSEcCtD
Midazolam—Connective tissue disorder—Temozolomide—malignant glioma	0.000625	0.0102	CcSEcCtD
Midazolam—Eye disorder—Carmustine—malignant glioma	0.000615	0.01	CcSEcCtD
Midazolam—Visual impairment—Temozolomide—malignant glioma	0.000613	0.01	CcSEcCtD
Midazolam—Clotiazepam—CYP2B6—malignant glioma	0.000612	0.108	CrCbGaD
Midazolam—GABRG2—brain—malignant glioma	0.000607	0.0058	CbGeAlD
Midazolam—GABRB2—brain—malignant glioma	0.000607	0.0058	CbGeAlD
Midazolam—Eye disorder—Temozolomide—malignant glioma	0.000595	0.0097	CcSEcCtD
Midazolam—Cardiac disorder—Temozolomide—malignant glioma	0.00059	0.00964	CcSEcCtD
Midazolam—GABRB3—central nervous system—malignant glioma	0.000587	0.00561	CbGeAlD
Midazolam—Clobazam—CYP2B6—malignant glioma	0.000578	0.102	CrCbGaD
Midazolam—Mental disorder—Carmustine—malignant glioma	0.000577	0.00941	CcSEcCtD
Midazolam—Immune system disorder—Temozolomide—malignant glioma	0.000575	0.00938	CcSEcCtD
Midazolam—GABRB3—cerebellum—malignant glioma	0.000573	0.00549	CbGeAlD
Midazolam—Mediastinal disorder—Temozolomide—malignant glioma	0.000573	0.00936	CcSEcCtD
Midazolam—Erythema—Carmustine—malignant glioma	0.000573	0.00935	CcSEcCtD
Midazolam—Chills—Temozolomide—malignant glioma	0.000571	0.00932	CcSEcCtD
Midazolam—Mental disorder—Temozolomide—malignant glioma	0.000557	0.0091	CcSEcCtD
Midazolam—GABRA2—brain—malignant glioma	0.000554	0.0053	CbGeAlD
Midazolam—Erythema—Temozolomide—malignant glioma	0.000554	0.00904	CcSEcCtD
Midazolam—GABRE—brain—malignant glioma	0.00055	0.00526	CbGeAlD
Midazolam—Vision blurred—Carmustine—malignant glioma	0.00054	0.00882	CcSEcCtD
Midazolam—Tremor—Carmustine—malignant glioma	0.000537	0.00876	CcSEcCtD
Midazolam—GABRA1—brain—malignant glioma	0.000536	0.00512	CbGeAlD
Midazolam—Flunitrazepam—CYP2B6—malignant glioma	0.000529	0.0932	CrCbGaD
Midazolam—Agitation—Carmustine—malignant glioma	0.000527	0.0086	CcSEcCtD
Midazolam—SLC22A1—brain—malignant glioma	0.000523	0.00501	CbGeAlD
Midazolam—Vision blurred—Temozolomide—malignant glioma	0.000522	0.00852	CcSEcCtD
Midazolam—Tremor—Temozolomide—malignant glioma	0.000519	0.00847	CcSEcCtD
Midazolam—CYP2E1—medulla oblongata—malignant glioma	0.000516	0.00494	CbGeAlD
Midazolam—Agitation—Temozolomide—malignant glioma	0.000509	0.00831	CcSEcCtD
Midazolam—Vertigo—Temozolomide—malignant glioma	0.000498	0.00812	CcSEcCtD
Midazolam—Anxiety—Carmustine—malignant glioma	0.000486	0.00794	CcSEcCtD
Midazolam—Cough—Temozolomide—malignant glioma	0.000483	0.00789	CcSEcCtD
Midazolam—Confusional state—Carmustine—malignant glioma	0.000472	0.0077	CcSEcCtD
Midazolam—Anxiety—Temozolomide—malignant glioma	0.00047	0.00767	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000468	0.00764	CcSEcCtD
Midazolam—GABRB3—brain—malignant glioma	0.000466	0.00446	CbGeAlD
Midazolam—Dry mouth—Temozolomide—malignant glioma	0.000461	0.00753	CcSEcCtD
Midazolam—CYP2E1—spinal cord—malignant glioma	0.00046	0.0044	CbGeAlD
Midazolam—ABCB1—embryo—malignant glioma	0.00046	0.0044	CbGeAlD
Midazolam—Tachycardia—Carmustine—malignant glioma	0.000456	0.00745	CcSEcCtD
Midazolam—Confusional state—Temozolomide—malignant glioma	0.000456	0.00744	CcSEcCtD
Midazolam—Diazepam—CYP2C18—malignant glioma	0.000454	0.08	CrCbGaD
Midazolam—Anaphylactic shock—Temozolomide—malignant glioma	0.000452	0.00738	CcSEcCtD
Midazolam—Nervous system disorder—Temozolomide—malignant glioma	0.000443	0.00724	CcSEcCtD
Midazolam—Skin disorder—Temozolomide—malignant glioma	0.000439	0.00717	CcSEcCtD
Midazolam—Hypotension—Carmustine—malignant glioma	0.000437	0.00713	CcSEcCtD
Midazolam—Paraesthesia—Carmustine—malignant glioma	0.00042	0.00686	CcSEcCtD
Midazolam—Dyspnoea—Carmustine—malignant glioma	0.000417	0.00681	CcSEcCtD
Midazolam—Somnolence—Carmustine—malignant glioma	0.000416	0.00679	CcSEcCtD
Midazolam—ABCB1—retina—malignant glioma	0.000407	0.00389	CbGeAlD
Midazolam—Temazepam—CYP2B6—malignant glioma	0.000406	0.0715	CrCbGaD
Midazolam—Paraesthesia—Temozolomide—malignant glioma	0.000406	0.00662	CcSEcCtD
Midazolam—Gastrointestinal disorder—Carmustine—malignant glioma	0.000404	0.00659	CcSEcCtD
Midazolam—Dyspnoea—Temozolomide—malignant glioma	0.000403	0.00658	CcSEcCtD
Midazolam—Somnolence—Temozolomide—malignant glioma	0.000402	0.00656	CcSEcCtD
Midazolam—Constipation—Carmustine—malignant glioma	0.0004	0.00653	CcSEcCtD
Midazolam—Pain—Carmustine—malignant glioma	0.0004	0.00653	CcSEcCtD
Midazolam—Dyspepsia—Temozolomide—malignant glioma	0.000398	0.00649	CcSEcCtD
Midazolam—CYP2B6—central nervous system—malignant glioma	0.000398	0.00381	CbGeAlD
Midazolam—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00039	0.00637	CcSEcCtD
Midazolam—Fatigue—Temozolomide—malignant glioma	0.00039	0.00636	CcSEcCtD
Midazolam—Pain—Temozolomide—malignant glioma	0.000387	0.00631	CcSEcCtD
Midazolam—Constipation—Temozolomide—malignant glioma	0.000387	0.00631	CcSEcCtD
Midazolam—Feeling abnormal—Carmustine—malignant glioma	0.000385	0.00629	CcSEcCtD
Midazolam—ABCB1—telencephalon—malignant glioma	0.000374	0.00358	CbGeAlD
Midazolam—CYP2E1—central nervous system—malignant glioma	0.000373	0.00357	CbGeAlD
Midazolam—Feeling abnormal—Temozolomide—malignant glioma	0.000372	0.00608	CcSEcCtD
Midazolam—CYP2E1—cerebellum—malignant glioma	0.000365	0.00349	CbGeAlD
Midazolam—Urticaria—Temozolomide—malignant glioma	0.000359	0.00586	CcSEcCtD
Midazolam—Hypersensitivity—Carmustine—malignant glioma	0.000345	0.00562	CcSEcCtD
Midazolam—Diazepam—CYP2B6—malignant glioma	0.000337	0.0594	CrCbGaD
Midazolam—Asthenia—Carmustine—malignant glioma	0.000336	0.00548	CcSEcCtD
Midazolam—Hypersensitivity—Temozolomide—malignant glioma	0.000333	0.00544	CcSEcCtD
Midazolam—Asthenia—Temozolomide—malignant glioma	0.000324	0.00529	CcSEcCtD
Midazolam—Pruritus—Temozolomide—malignant glioma	0.00032	0.00522	CcSEcCtD
Midazolam—CYP2B6—brain—malignant glioma	0.000316	0.00302	CbGeAlD
Midazolam—Dizziness—Carmustine—malignant glioma	0.000309	0.00505	CcSEcCtD
Midazolam—CYP3A4—central nervous system—malignant glioma	0.0003	0.00287	CbGeAlD
Midazolam—Dizziness—Temozolomide—malignant glioma	0.000299	0.00488	CcSEcCtD
Midazolam—Vomiting—Carmustine—malignant glioma	0.000297	0.00485	CcSEcCtD
Midazolam—CYP2E1—brain—malignant glioma	0.000296	0.00284	CbGeAlD
Midazolam—Rash—Carmustine—malignant glioma	0.000295	0.00481	CcSEcCtD
Midazolam—Dermatitis—Carmustine—malignant glioma	0.000295	0.00481	CcSEcCtD
Midazolam—ABCB1—medulla oblongata—malignant glioma	0.000294	0.00281	CbGeAlD
Midazolam—Headache—Carmustine—malignant glioma	0.000293	0.00478	CcSEcCtD
Midazolam—Vomiting—Temozolomide—malignant glioma	0.000287	0.00469	CcSEcCtD
Midazolam—Rash—Temozolomide—malignant glioma	0.000285	0.00465	CcSEcCtD
Midazolam—Dermatitis—Temozolomide—malignant glioma	0.000285	0.00465	CcSEcCtD
Midazolam—Headache—Temozolomide—malignant glioma	0.000283	0.00462	CcSEcCtD
Midazolam—Nausea—Carmustine—malignant glioma	0.000278	0.00453	CcSEcCtD
Midazolam—ABCB1—midbrain—malignant glioma	0.000269	0.00257	CbGeAlD
Midazolam—Nausea—Temozolomide—malignant glioma	0.000268	0.00438	CcSEcCtD
Midazolam—ABCB1—spinal cord—malignant glioma	0.000262	0.00251	CbGeAlD
Midazolam—Diazepam—PTGS1—malignant glioma	0.000222	0.0391	CrCbGaD
Midazolam—ABCB1—central nervous system—malignant glioma	0.000213	0.00203	CbGeAlD
Midazolam—ABCB1—cerebellum—malignant glioma	0.000208	0.00199	CbGeAlD
Midazolam—ABCB1—brain—malignant glioma	0.000169	0.00162	CbGeAlD
Midazolam—GABRB3—Neuronal System—MDM2—malignant glioma	4.3e-05	0.000298	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—RAF1—malignant glioma	4.29e-05	0.000297	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ASMT—malignant glioma	4.28e-05	0.000296	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—TFRC—malignant glioma	4.28e-05	0.000296	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—PTGS1—malignant glioma	4.23e-05	0.000293	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—MDM2—malignant glioma	4.23e-05	0.000293	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—RAF1—malignant glioma	4.21e-05	0.000292	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—BCHE—malignant glioma	4.14e-05	0.000287	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—MDM2—malignant glioma	4.13e-05	0.000286	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—RAF1—malignant glioma	4.11e-05	0.000285	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	4.11e-05	0.000285	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—SLC5A5—malignant glioma	4.09e-05	0.000283	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—BCAN—malignant glioma	4.02e-05	0.000279	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—COX8A—malignant glioma	4e-05	0.000277	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CAV1—malignant glioma	3.95e-05	0.000273	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.93e-05	0.000272	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—COX8A—malignant glioma	3.92e-05	0.000271	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—COX8A—malignant glioma	3.91e-05	0.000271	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—VEGFA—malignant glioma	3.86e-05	0.000268	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	3.83e-05	0.000265	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—BRAF—malignant glioma	3.77e-05	0.000261	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.77e-05	0.000261	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.74e-05	0.000259	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.74e-05	0.000259	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—MDM2—malignant glioma	3.69e-05	0.000256	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—RAF1—malignant glioma	3.68e-05	0.000255	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	3.67e-05	0.000254	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CG—malignant glioma	3.59e-05	0.000249	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.57e-05	0.000247	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—RAF1—malignant glioma	3.57e-05	0.000247	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	3.54e-05	0.000245	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—IDH2—malignant glioma	3.48e-05	0.000241	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PPARG—malignant glioma	3.47e-05	0.00024	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ASMT—malignant glioma	3.4e-05	0.000236	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ASMT—malignant glioma	3.33e-05	0.000231	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ASMT—malignant glioma	3.32e-05	0.00023	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TNF—malignant glioma	3.31e-05	0.000229	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GSTP1—malignant glioma	3.3e-05	0.000228	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	3.29e-05	0.000228	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP2B6—malignant glioma	3.28e-05	0.000227	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—IDH2—malignant glioma	3.24e-05	0.000225	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CAT—malignant glioma	3.21e-05	0.000222	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—BCAN—malignant glioma	3.2e-05	0.000221	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	3.19e-05	0.000221	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—RTEL1—malignant glioma	3.16e-05	0.000219	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—MDM2—malignant glioma	3.16e-05	0.000219	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CD—malignant glioma	3.16e-05	0.000219	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—RAF1—malignant glioma	3.15e-05	0.000218	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	3.15e-05	0.000218	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—BCAN—malignant glioma	3.13e-05	0.000217	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.13e-05	0.000217	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—BCAN—malignant glioma	3.12e-05	0.000216	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.09e-05	0.000214	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP2B6—malignant glioma	3.05e-05	0.000211	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—NCOR1—malignant glioma	3.03e-05	0.00021	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—IDH1—malignant glioma	3e-05	0.000208	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—COX8A—malignant glioma	2.95e-05	0.000204	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.94e-05	0.000204	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SPHK1—malignant glioma	2.9e-05	0.000201	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.9e-05	0.000201	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	2.84e-05	0.000197	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP2C18—malignant glioma	2.84e-05	0.000197	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—IDH1—malignant glioma	2.79e-05	0.000193	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CB—malignant glioma	2.75e-05	0.000191	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—RAF1—malignant glioma	2.74e-05	0.00019	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PTGS2—malignant glioma	2.73e-05	0.000189	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—RAF1—malignant glioma	2.71e-05	0.000188	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SPHK1—malignant glioma	2.7e-05	0.000187	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	2.68e-05	0.000186	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP2C18—malignant glioma	2.64e-05	0.000183	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—IDH2—malignant glioma	2.58e-05	0.000178	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	2.55e-05	0.000176	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—IDH2—malignant glioma	2.52e-05	0.000175	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—IDH2—malignant glioma	2.52e-05	0.000174	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	2.51e-05	0.000174	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ASMT—malignant glioma	2.51e-05	0.000174	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	2.51e-05	0.000174	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	2.5e-05	0.000173	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.48e-05	0.000172	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	2.47e-05	0.000171	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CAV1—malignant glioma	2.47e-05	0.000171	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	2.42e-05	0.000168	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	2.41e-05	0.000167	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PTEN—malignant glioma	2.38e-05	0.000165	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP2B6—malignant glioma	2.37e-05	0.000164	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP2B6—malignant glioma	2.37e-05	0.000164	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.36e-05	0.000164	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—BCAN—malignant glioma	2.36e-05	0.000163	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.32e-05	0.000161	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.31e-05	0.00016	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.3e-05	0.000159	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTT1—malignant glioma	2.3e-05	0.000159	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.26e-05	0.000157	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CG—malignant glioma	2.25e-05	0.000156	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	2.25e-05	0.000156	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—IDH1—malignant glioma	2.22e-05	0.000153	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.19e-05	0.000152	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PPARG—malignant glioma	2.17e-05	0.00015	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—IDH1—malignant glioma	2.17e-05	0.00015	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—IDH1—malignant glioma	2.17e-05	0.00015	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS1—malignant glioma	2.15e-05	0.000149	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SPHK1—malignant glioma	2.14e-05	0.000149	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTT1—malignant glioma	2.14e-05	0.000148	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	2.11e-05	0.000146	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP2C18—malignant glioma	2.1e-05	0.000145	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SPHK1—malignant glioma	2.1e-05	0.000145	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SPHK1—malignant glioma	2.1e-05	0.000145	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP2C18—malignant glioma	2.06e-05	0.000143	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP2C18—malignant glioma	2.05e-05	0.000142	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS1—malignant glioma	2e-05	0.000139	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—BCHE—malignant glioma	2e-05	0.000139	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.98e-05	0.000137	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CD—malignant glioma	1.98e-05	0.000137	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SLC5A5—malignant glioma	1.98e-05	0.000137	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.91e-05	0.000132	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—IDH2—malignant glioma	1.9e-05	0.000132	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—BCHE—malignant glioma	1.86e-05	0.000129	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SLC5A5—malignant glioma	1.84e-05	0.000127	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—COX8A—malignant glioma	1.82e-05	0.000126	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP2B6—malignant glioma	1.79e-05	0.000124	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.75e-05	0.000121	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CB—malignant glioma	1.72e-05	0.000119	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.71e-05	0.000119	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTGS2—malignant glioma	1.71e-05	0.000118	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTT1—malignant glioma	1.7e-05	0.000118	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.69e-05	0.000117	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CA—malignant glioma	1.68e-05	0.000116	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTT1—malignant glioma	1.66e-05	0.000115	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTT1—malignant glioma	1.66e-05	0.000115	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—IDH1—malignant glioma	1.63e-05	0.000113	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.63e-05	0.000113	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.62e-05	0.000112	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTP1—malignant glioma	1.59e-05	0.00011	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS1—malignant glioma	1.59e-05	0.00011	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SPHK1—malignant glioma	1.58e-05	0.00011	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS1—malignant glioma	1.56e-05	0.000108	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS1—malignant glioma	1.56e-05	0.000108	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CAT—malignant glioma	1.55e-05	0.000107	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP2C18—malignant glioma	1.55e-05	0.000107	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ASMT—malignant glioma	1.54e-05	0.000107	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTEN—malignant glioma	1.49e-05	0.000103	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.49e-05	0.000103	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTP1—malignant glioma	1.48e-05	0.000103	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—BCHE—malignant glioma	1.48e-05	0.000103	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—NCOR1—malignant glioma	1.46e-05	0.000101	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.46e-05	0.000101	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BCAN—malignant glioma	1.45e-05	0.000101	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—BCHE—malignant glioma	1.45e-05	0.0001	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—BCHE—malignant glioma	1.45e-05	0.0001	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CAT—malignant glioma	1.44e-05	9.99e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.44e-05	9.97e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC5A5—malignant glioma	1.43e-05	9.92e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.43e-05	9.9e-05	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—AKT1—malignant glioma	1.37e-05	9.5e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NCOR1—malignant glioma	1.36e-05	9.43e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTT1—malignant glioma	1.25e-05	8.68e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.22e-05	8.42e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CAV1—malignant glioma	1.19e-05	8.26e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTP1—malignant glioma	1.18e-05	8.16e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS1—malignant glioma	1.17e-05	8.13e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—IDH2—malignant glioma	1.17e-05	8.11e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTP1—malignant glioma	1.15e-05	7.99e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTP1—malignant glioma	1.15e-05	7.97e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CAT—malignant glioma	1.15e-05	7.94e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CAT—malignant glioma	1.12e-05	7.77e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CAT—malignant glioma	1.12e-05	7.76e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CAV1—malignant glioma	1.11e-05	7.69e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.1e-05	7.63e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—BCHE—malignant glioma	1.09e-05	7.56e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CG—malignant glioma	1.09e-05	7.53e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NCOR1—malignant glioma	1.08e-05	7.5e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC5A5—malignant glioma	1.08e-05	7.47e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NCOR1—malignant glioma	1.06e-05	7.34e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NCOR1—malignant glioma	1.06e-05	7.33e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CA—malignant glioma	1.05e-05	7.28e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPARG—malignant glioma	1.05e-05	7.26e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CG—malignant glioma	1.01e-05	7e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—IDH1—malignant glioma	1.01e-05	6.97e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	9.93e-06	6.88e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPARG—malignant glioma	9.76e-06	6.76e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SPHK1—malignant glioma	9.74e-06	6.75e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CD—malignant glioma	9.55e-06	6.62e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.54e-06	6.61e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CD—malignant glioma	8.89e-06	6.16e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CAV1—malignant glioma	8.82e-06	6.11e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTP1—malignant glioma	8.68e-06	6.02e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CAV1—malignant glioma	8.64e-06	5.98e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CAV1—malignant glioma	8.62e-06	5.97e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AKT1—malignant glioma	8.58e-06	5.95e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CAT—malignant glioma	8.45e-06	5.85e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CB—malignant glioma	8.32e-06	5.77e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS2—malignant glioma	8.25e-06	5.71e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CG—malignant glioma	8.03e-06	5.57e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NCOR1—malignant glioma	7.98e-06	5.53e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CG—malignant glioma	7.87e-06	5.45e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CG—malignant glioma	7.85e-06	5.44e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPARG—malignant glioma	7.75e-06	5.37e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CB—malignant glioma	7.75e-06	5.37e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTT1—malignant glioma	7.72e-06	5.35e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS2—malignant glioma	7.68e-06	5.32e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPARG—malignant glioma	7.59e-06	5.26e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPARG—malignant glioma	7.58e-06	5.25e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS1—malignant glioma	7.23e-06	5.01e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTEN—malignant glioma	7.19e-06	4.98e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CD—malignant glioma	7.06e-06	4.89e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CD—malignant glioma	6.92e-06	4.79e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CD—malignant glioma	6.9e-06	4.78e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BCHE—malignant glioma	6.72e-06	4.66e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTEN—malignant glioma	6.69e-06	4.64e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.64e-06	4.6e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CAV1—malignant glioma	6.51e-06	4.51e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CB—malignant glioma	6.16e-06	4.26e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS2—malignant glioma	6.1e-06	4.23e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CB—malignant glioma	6.03e-06	4.18e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CB—malignant glioma	6.02e-06	4.17e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS2—malignant glioma	5.97e-06	4.14e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS2—malignant glioma	5.96e-06	4.13e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CG—malignant glioma	5.93e-06	4.1e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPARG—malignant glioma	5.72e-06	3.96e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTP1—malignant glioma	5.35e-06	3.71e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTEN—malignant glioma	5.32e-06	3.69e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTEN—malignant glioma	5.21e-06	3.61e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CD—malignant glioma	5.21e-06	3.61e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CAT—malignant glioma	5.21e-06	3.61e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTEN—malignant glioma	5.2e-06	3.6e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CA—malignant glioma	5.07e-06	3.52e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NCOR1—malignant glioma	4.92e-06	3.41e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CA—malignant glioma	4.72e-06	3.27e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CB—malignant glioma	4.54e-06	3.15e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS2—malignant glioma	4.5e-06	3.12e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKT1—malignant glioma	4.15e-06	2.87e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CAV1—malignant glioma	4.01e-06	2.78e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTEN—malignant glioma	3.92e-06	2.72e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKT1—malignant glioma	3.86e-06	2.67e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.75e-06	2.6e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CA—malignant glioma	3.68e-06	2.55e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.67e-06	2.54e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.65e-06	2.53e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPARG—malignant glioma	3.52e-06	2.44e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.21e-06	2.22e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKT1—malignant glioma	3.07e-06	2.12e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKT1—malignant glioma	3e-06	2.08e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKT1—malignant glioma	3e-06	2.08e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.8e-06	1.94e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS2—malignant glioma	2.77e-06	1.92e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CA—malignant glioma	2.77e-06	1.92e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTEN—malignant glioma	2.42e-06	1.67e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKT1—malignant glioma	2.26e-06	1.57e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.71e-06	1.18e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKT1—malignant glioma	1.39e-06	9.65e-06	CbGpPWpGaD
